99 related articles for article (PubMed ID: 27582550)
1. Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma.
Xie N; Wang C; Zhuang Z; Hou J; Liu X; Wu Y; Liu H; Huang H
Oncotarget; 2016 Oct; 7(40):65744-65757. PubMed ID: 27582550
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor.
Hou C; Dong Y; Zhang F; Du B
Mol Med Rep; 2017 Nov; 16(5):7245-7252. PubMed ID: 28944863
[TBL] [Abstract][Full Text] [Related]
4. Brucea javanica oil inhibits tongue squamous cell invasion and metastasis by regulating miR-138-EZH2 pathway.
Jiang L; Zhou J; Wu Y; Zhou L; Zhang C; Zhu J; Fang Z; Shao Y; Wang W
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101611. PubMed ID: 37619672
[TBL] [Abstract][Full Text] [Related]
5. Suppression of N-Glycosylation of Zinc Finger Protein 471 Affects Proliferation, Invasion, and Docetaxel Sensitivity of Tongue Squamous Cell Carcinoma via Regulation of c-Myc.
Liu Y; Cai X; Hu S; Wang Z; Tian H; Wang H
Am J Pathol; 2024 Jun; 194(6):1106-1125. PubMed ID: 38749608
[TBL] [Abstract][Full Text] [Related]
6. SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter.
Zhu M; Ma Y; Wang W; Li M; Chen S; Liu F; Shi X; Bi H; Zhang C; Nie F; Zheng H; Zhang C
Mol Cancer Res; 2024 May; 22(5):482-494. PubMed ID: 38349738
[TBL] [Abstract][Full Text] [Related]
7. A three-long non-coding RNA signature that predicts tongue squamous cell carcinoma prognosis.
Li R; Li F; Wang Y; An P; Hu Y; Xu J; Zhao L; Lin X
Oral Dis; 2023 Mar; 29(2):557-562. PubMed ID: 34318582
[No Abstract] [Full Text] [Related]
8. Tumor-derived small extracellular vesicles facilitate omental metastasis of ovarian cancer by triggering activation of mesenchymal stem cells.
Gong L; Li G; Yi X; Han Q; Wu Q; Ying F; Shen L; Cao Y; Liu X; Gao L; Li W; Wang Z; Cai J
Cell Commun Signal; 2024 Jan; 22(1):47. PubMed ID: 38233863
[TBL] [Abstract][Full Text] [Related]
9. Trichosanthin cooperates with Granzyme B to restrain tumor formation in tongue squamous cell carcinoma.
Zhu Z; Ying Z; Zeng M; Zhang Q; Liao G; Liang Y; Li C; Zhang C; Wang X; Jiang W; Luan P; Sha O
BMC Complement Med Ther; 2021 Mar; 21(1):88. PubMed ID: 33750370
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.
Sun Y; Li Y; Zhou W; Liu Z
BMC Oral Health; 2024 Mar; 24(1):406. PubMed ID: 38556858
[TBL] [Abstract][Full Text] [Related]
11. Isolation of differentiated squamous and undifferentiated spindle carcinoma cell lines with differing metastatic potential from a 4-nitroquinoline N-Oxide-induced tongue carcinoma in a F344 rat.
Takeuchi S; Nakanishi H; Yoshida K; Yamamoto S; Tonoki H; Tsukamoto T; Fukushima S; Moriuchi T; Kurita K; Tatematsu M
Jpn J Cancer Res; 2000 Dec; 91(12):1211-21. PubMed ID: 11123419
[TBL] [Abstract][Full Text] [Related]
12. p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA-320a in lung cancer.
Xing A; Pan L; Gao J
Thorac Cancer; 2018 Jan; 9(1):152-158. PubMed ID: 29159900
[TBL] [Abstract][Full Text] [Related]
13. Rab25 regulates invasion and metastasis in head and neck cancer.
Amornphimoltham P; Rechache K; Thompson J; Masedunskas A; Leelahavanichkul K; Patel V; Molinolo A; Gutkind JS; Weigert R
Clin Cancer Res; 2013 Mar; 19(6):1375-88. PubMed ID: 23340300
[TBL] [Abstract][Full Text] [Related]
14. RFC4 promotes the progression and growth of Oral Tongue squamous cell carcinoma in vivo and vitro.
Zhang J; Wang L; Xie X
J Clin Lab Anal; 2021 May; 35(5):e23761. PubMed ID: 33783864
[TBL] [Abstract][Full Text] [Related]
15. miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.
Kaid C; Jordan D; Bueno HMS; Araujo BHS; Assoni A; Okamoto OK
Mol Oncol; 2019 Dec; 13(12):2574-2587. PubMed ID: 31402560
[TBL] [Abstract][Full Text] [Related]
16. MiR-320a Acts as a Tumor Suppressor in Somatotroph Pituitary Neuroendocrine Tumors by Targeting BCAT1.
Zhao S; Li B; Gao H; Zhang Y
Neuroendocrinology; 2024; 114(1):14-24. PubMed ID: 37591221
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-320a enhances LRWD1 expression through the AGO2/FXR1-dependent pathway to affect cell behaviors and the oxidative stress response in human testicular embryonic carcinoma cells.
Lin YH; Su CH; Chen HM; Wu MS; Pan HA; Chang CN; Cheng YS; Chang WT; Chiu CC; Teng YN
Aging (Albany NY); 2024 Feb; 16(4):3973-3988. PubMed ID: 38385979
[TBL] [Abstract][Full Text] [Related]
18. RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma.
Matsuzaki Y; Naito Y; Miura N; Mori T; Watabe Y; Yoshimoto S; Shibahara T; Takano M; Honda K
Curr Oncol; 2022 Dec; 30(1):381-391. PubMed ID: 36661680
[TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics analysis of SEMA3C in tongue squamous cell carcinoma using machine-learning strategies.
Dou H; Song C; Wang X; Feng Z; Su Y; Wang H
Cancer Cell Int; 2024 Feb; 24(1):58. PubMed ID: 38321460
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of miR-320a in lung cancer: a comprehensive review.
Mohanta A; Kumar RR; Singh RK; Mandal S; Yadav R; Khatkar R; Sharma U; Uttam V; Rana MK; Rana AP; Jain A
Biomark Med; 2023 Sep; 17(18):767-781. PubMed ID: 38095986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
